NSAIDs must display warning about pregnancy complications, FDA says

NSAIDs deal with discomfort and fever by avoiding the bodys formation of specific chemicals that cause inflammation. Some NSAIDs are over the counter, and others require a prescription. Typically taken NSAIDs include ibuprofen (frequently sold under the trademark name Advil and Motrin), naproxen (often offered under the brand names Aleve and some types of Midol) and diclofenac (typically offered under the brand Voltaren and Cambia).

The company stated the labeling changes must describe that taking the medication around 20 weeks of later on in a pregnancy could cause important kidney problems in the fetus, potentially resulting in low levels of amniotic fluid that could trigger further complications in utero.

Katie Adams –
Friday, October 16th, 2020

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by click on this link.

” It is very important that ladies understand the advantages and threats of the medications they might take over the course of their pregnancy,” Patrizia Cavazzoni, MD, the acting director of the FDAs Center for Drug Evaluation and Research, stated in a press release. “To this end, the firm is utilizing its regulatory authority to inform females and their health care suppliers about the risks if NSAIDs are used after around 20 weeks of pregnancy and beyond.”.


More articles on pharmacy: FDA grants first-ever Ebola drug approval to RegeneronWalgreens 4th-quarter sales at retail drug stores up 3.6% Operation Warp Speeds latest relocation: $31M to Cytiva to produce COVID-19 vaccine parts

The FDA now needs the bottle labeling or recommending details for nonsteroidal anti-inflammatory drugs to divulge the threats related to their use in people who are pregnant, the company announced Oct. 15.